GangaGen Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Private

  • Employees
  • 57

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 3

GangaGen General Information

Description

Developer of engineering novel treatments designed to prevent bacterial infections that are resistant to antibiotics. The company's treatment is a recombinant protein that binds to and kills Staphylococcus, including methicillin-resistant strains of S.aureus (MRSA) offers a highly innovative approach to treat infections caused by multidrug-resistant Klebsiella pneumonia, including the carbapenem-resistant and Extended-Spectrum ß-Lactamase (ESBL)-expressing strains of particular clinical concern, enabling clinicians to combat life-threatening infections such as pneumonia and neonatal sepsis.

Contact Information

Website
www.gangagen.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Number 12, 5th Cross, Raghavendra Layout
  • Opposite MEI Ltd, Tumkur Road, Yeshwanthpur
  • Bangalore, 560022
  • India
+91 080
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Life Sciences
Corporate Office
  • Number 12, 5th Cross, Raghavendra Layout
  • Opposite MEI Ltd, Tumkur Road, Yeshwanthpur
  • Bangalore, 560022
  • India
+91 080

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

GangaGen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Secondary Transaction - Private Completed Profitable
9. Grant 10-Aug-2023 Completed Profitable
8. Grant 05-Oct-2020 Completed Profitable
7. Later Stage VC (Series E) 07-Oct-2008 Completed Profitable
6. Later Stage VC (Series D) Completed Generating Revenue
5. Later Stage VC 06-Dec-2006 Completed Generating Revenue
4. Later Stage VC (Series C) 12-Jan-2006 Completed Generating Revenue
3. Later Stage VC 28-Nov-2005 Completed Startup
2. Early Stage VC (Series B) 15-May-2003 $1.91M $1.91M Completed Startup
1. Early Stage VC (Series A) Completed Startup
To view GangaGen’s complete valuation and funding history, request access »

GangaGen Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of engineering novel treatments designed to prevent bacterial infections that are resistant to antibiotics. Th
Biotechnology
Bangalore, India
57 As of 2022

Gaithersburg, MD
 

Aberdeen, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

GangaGen Competitors (55)

One of GangaGen’s 55 competitors is BiomX, a Formerly VC-backed company based in Gaithersburg, MD.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
BiomX Formerly VC-backed Gaithersburg, MD
NovaBiotics Venture Capital-Backed Aberdeen, United Kingdom
Eligo Bioscience Venture Capital-Backed Paris, France
SynDevRx Venture Capital-Backed Cambridge, MA
Light Chain Bioscience Formerly PE-Backed Geneva, Switzerland
You’re viewing 5 of 55 competitors. Get the full list »

GangaGen Patents

  • 110

    Total Documents Applications and Grants

  • Total Patents Families

  • 54

    Granted

  • 17

    Pending

  • Expiring in next 12 mo

GangaGen Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240010689-A1 Chimeric klebicins Pending 08-Jul-2022
JP-2024527605-A Chimeric klebisin Pending 12-Jul-2021
EP-4370533-A2 Chimeric klebicins Pending 12-Jul-2021
CA-3225734-A1 Chimeric klebicins Pending 12-Jul-2021
US-20240317819-A1 Chimeric klebicins Pending 12-Jul-2021 C07K14/26
To view GangaGen’s complete patent history, request access »

GangaGen Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

GangaGen Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
CARB-X University
ATEL Capital Group Asset Manager Minority
Otsuka Pharmaceutical Corporation Minority
To view GangaGen’s complete investors history, request access »

Ready to get started?

Request a free trial

GangaGen FAQs

  • When was GangaGen founded?

    GangaGen was founded in 2000.

  • Where is GangaGen headquartered?

    GangaGen is headquartered in Bangalore, India.

  • What is the size of GangaGen?

    GangaGen has 57 total employees.

  • What industry is GangaGen in?

    GangaGen’s primary industry is Biotechnology.

  • Is GangaGen a private or public company?

    GangaGen is a Private company.

  • What is GangaGen’s current revenue?

    The current revenue for GangaGen is .

  • How much funding has GangaGen raised over time?

    GangaGen has raised $14.1M.

  • Who are GangaGen’s investors?

    CARB-X, ATEL Capital Group, and Otsuka Pharmaceutical have invested in GangaGen.

  • Who are GangaGen’s competitors?

    BiomX, NovaBiotics, Eligo Bioscience, SynDevRx, and Light Chain Bioscience are some of the 55 competitors of GangaGen.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »